Morgan Stanley Boosts Phibro Animal Health (PAHC) Price Target to $36.00
Phibro Animal Health (NASDAQ:PAHC) had its price target lifted by Morgan Stanley from $30.00 to $36.00 in a research note released on Wednesday morning. They currently have an underweight rating on the stock.
Several other equities analysts have also recently weighed in on the company. BidaskClub cut Phibro Animal Health from a sell rating to a strong sell rating in a research report on Tuesday, December 12th. Piper Jaffray Companies reissued a buy rating and set a $42.00 price objective on shares of Phibro Animal Health in a research report on Friday, November 10th. Zacks Investment Research raised Phibro Animal Health from a sell rating to a hold rating in a research report on Monday, January 8th. Finally, ValuEngine cut Phibro Animal Health from a buy rating to a hold rating in a research report on Thursday, November 9th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. Phibro Animal Health has a consensus rating of Hold and an average price target of $38.20.
Shares of Phibro Animal Health (PAHC) opened at $35.55 on Wednesday. Phibro Animal Health has a 12-month low of $26.70 and a 12-month high of $40.25. The firm has a market capitalization of $1,420.47, a PE ratio of 23.24, a price-to-earnings-growth ratio of 2.51 and a beta of 1.18. The company has a debt-to-equity ratio of 1.82, a current ratio of 3.12 and a quick ratio of 1.85.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 28th. Investors of record on Wednesday, March 7th will be given a dividend of $0.10 per share. The ex-dividend date is Tuesday, March 6th. This represents a $0.40 annualized dividend and a dividend yield of 1.13%. Phibro Animal Health’s dividend payout ratio is presently 26.14%.
Several hedge funds and other institutional investors have recently bought and sold shares of PAHC. First Manhattan Co. acquired a new position in shares of Phibro Animal Health during the 4th quarter worth about $100,000. Dean Capital Investments Management LLC acquired a new position in shares of Phibro Animal Health during the 4th quarter worth about $200,000. Susquehanna International Group LLP acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth about $219,000. Teacher Retirement System of Texas acquired a new position in shares of Phibro Animal Health during the 4th quarter worth about $224,000. Finally, Crossmark Global Holdings Inc. acquired a new position in shares of Phibro Animal Health during the 4th quarter worth about $253,000. 48.31% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.watchlistnews.com/morgan-stanley-boosts-phibro-animal-health-pahc-price-target-to-36-00/1859085.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.